Risk factors of transmission and natural history of chronic hepatitis B infection in Iranian patients

Aim: To investigate routes of transmission, demographic characteristics, and frequency of different phases of chronic hepatitis B (CHB) in 2000 Iranian patients. Background: Knowledge about the most frequent risk factors of CHB and its different phases is very important for optimal prevention and management policy making. Methods: In this cross-sectional study, 2000 HBsAg positive patients who were referred to Taleghani Hospital from 2011 through 2018 were enrolled. ELISA method was employed to detect serological markers of CHB. Taking into account the HBV DNA and ALT levels and HBeAg status, the patients were classified in four groups, according to AASLD 2017 guideline. Results: Male and female patients had nearly equal frequencies in our study and 82.5 % of them aged more than 20 years. A great number of our patients (95%) were HBeAg negative and the most frequent risk factors of HBV infection were positive periodontal and family history (40.3% and 24.9%, respectively). The majority of our patients were inactive carriers (63.35%), while s mall number of them were in the immune tolerant group (2.15 %). Conclusion: Immune tolerance phase group had the minimum number of members in our study and most of them were above 20 years old. This can be due to the mass vaccination of neonates since 1993. Most of CHB patients were in inactive carrier group. Although it is recommended not to treat these patients, performing periodic liver function tests and disease severity assessment is warranted, especially in patients above 40 years old.

[1]  M. Rasouli,et al.  Dentists’ knowledge, attitudes and practices regarding Hepatitis B and C and HIV/AIDS in Sanandaj, Iran , 2018, BMC oral health.

[2]  A. Shayesteh,et al.  Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran , 2018, Asian Pacific journal of cancer prevention : APJCP.

[3]  M. Zali,et al.  Demographic changes of hepatitis B virus infection in Iran for the last two decades , 2017, Gastroenterology and hepatology from bed to bench.

[4]  T. Sevá-Pereira,et al.  Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors , 2017, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[5]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[6]  R. Malekzadeh,et al.  Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies , 2015, Middle East journal of digestive diseases.

[7]  A. de Gottardi,et al.  [Update Chronic Viral Hepatitis B and C]. , 2015, Praxis.

[8]  M. Kumar,et al.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update , 2015, Hepatology International.

[9]  R. Taherkhani,et al.  Epidemiology of hepatitis C virus in Iran. , 2015, World journal of gastroenterology.

[10]  P. Azimzadeh,et al.  The Early Results of a New Health Care Program Implementation in HBV Screening: an Iranian Experience , 2015, Middle East journal of digestive diseases.

[11]  Mohamad Amin Pourhoseingholi,et al.  Hepatocellular carcinoma in Asia: Prevention strategy and planning. , 2015, World journal of hepatology.

[12]  Chong Shen,et al.  Seroepidemiology of hepatitis B virus infection among Chinese schizophrenia patients. , 2015, Journal of infection in developing countries.

[13]  S. Alavian,et al.  Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients , 2015, Jundishapur journal of microbiology.

[14]  Kai Wang,et al.  Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection , 2015, Hepatology International.

[15]  R. Fontana,et al.  Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  R. Thimme,et al.  Natural history of chronic hepatitis B virus infection , 2015, Medical Microbiology and Immunology.

[17]  J. Lubel,et al.  Natural history of chronic hepatitis B: phases in a complex relationship. , 2014, World journal of gastroenterology.

[18]  Z. Sharifi Natural History of Chronic Hepatitis B Virus Infection Based on Laboratory Testing , 2014, Iranian journal of public health.

[19]  B. Aygen,et al.  The characteristics of patients with chronic hepatitis B in Turkey. , 2014, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.

[20]  M. Ziaee,et al.  Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012 , 2013, Hepatitis monthly.

[21]  Shigui Yang,et al.  Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study , 2013, Hepatitis monthly.

[22]  S. Alavian,et al.  Seroepidemiology of HBV Infection in South-East of Iran; A Population Based Study , 2012, Iranian Red Crescent medical journal.

[23]  S. Hadziyannis Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. , 2011, Journal of hepatology.

[24]  Chien-Jen Chen,et al.  Natural history of chronic hepatitis B REVEALed , 2011, Journal of gastroenterology and hepatology.

[25]  S. Lewin,et al.  Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers , 2010, Hepatology.

[26]  E. Sagnelli,et al.  Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study , 2009, Journal of medical virology.

[27]  R. Majdzadeh,et al.  Prevalence of chronic hepatitis B infection in Iran: a review article , 2009, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[28]  A. Nardone,et al.  A comparison of hepatitis B seroepidemiology in ten European countries , 2008, Epidemiology and Infection.

[29]  R. Talukdar,et al.  Management of patients with HBeAg-negative chronic hepatitis B , 2007, Postgraduate Medical Journal.

[30]  M. Khoshbaten,et al.  Hepatitis E virus infection in hemodialysis patients: A seroepidemiological survey in Iran , 2005, BMC infectious diseases.

[31]  Alavian SeyedMoayed,et al.  Risk Factors in Chronic Hepatitis B Infection: A Case-control Study , 2005 .

[32]  M. Akbari,et al.  Public health improvement in Iran--lessons from the last 20 years. , 2004, Public health.

[33]  G. Khademi,et al.  The prevalence of hepatitis B carrier state in Khorassan province of Iran. , 2003, Saudi medical journal.

[34]  Reza Malekzadeh,et al.  HEPATITIS B IN IRAN , 2000 .

[35]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.